Publications

• Coleridge Smith P. Management of reticular veins and telangiectases. Phlebology. 2015; 30(2 Suppl):46-52.
• Coleridge Smith P. Debate: should persistent incompetent truncal veins be treated immediately? The case in support of the statement. Phlebology. 2015; 30(1 Suppl):107-10.
• Willenberg T, Coleridge Smith P, Shepherd A, Davies AH. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review. Phlebology. 2013; 28: 123-31.
• Wittens CH, Bækgaard N, Smith PC, Rabe E, Pittaluga P, Labropoulos N. Manuscripts from the European venous course. Phlebology. 2013 Mar;28 Suppl 1:
• Rabe E, Breu F, Cavezzi A, Coleridge Smith P, Frullini A, Gillet J, Guex J, Hamel-Desnos C, Kern P, Partsch B, Ramelet A, Tessari L, Pannier F; for the Guideline Group. European guidelines for sclerotherapy in chronic venous disorders. Phlebology. 2013 Apr 4.
• Coleridge Smith P. The outcome of treatment for pelvic congestion syndrome. Phlebology. 2012 Mar;27 Suppl 1:74-7.
• De Maeseneer M, Pichot O, Cavezzi A, Earnshaw J, van Rij A, Lurie F, Coleridge Smith P; Union Internationale de Phlebologie. .Duplex ultrasound investigation of the veins of the lower limbs after treatment for varicose veins – UIP consensus document. Eur J Vasc Endovasc Surg. 2011; 42: 89-102.
• Coleridge Smith P. Varicose veins and chronic venous disease treatment by a new non-surgical method. NHS Healthcare – the way forward, NHS Trust Association,  2009: p 112-9.
• Coleridge Smith P. Five-year outcome of ultrasound-guided foam sclerotherapy for saphenous trunks. Phlebology 2009; 24: 215.
• Coleridge Smith-P . Sclerotherapy and foam sclerotherapy for varicose veins. Phlebology, 2009;  24: 260-9.
• Coleridge Smith P.     Foam and liquid sclerotherapy for varicose veins.     Phlebology, 2009:  24 (Supplement 1): 62—72.
• Coleridge Smith PD. Leg ulcer treatment. J Vasc Surg  2009; 49:804-808.
• Partsch H, Flour M, Smith PC; International Compression Club.  Indications for compression therapy in venous and lymphatic disease consensus based on experimental data and scientific evidence.  Int Angiol. 2008; 27: 193-219.
• Coleridge Smith P. Drug treatment of varicose veins, venous edema and ulcers. In ed.  Gloviczki P, Handbook of Venous Disorders: Guidelines of the American Venous Forum 3rd edition, Hodder Arnold, London, 2008.
• Coleridge Smith P. Foam Sclerotherapy, A Personal Method: Technique and Results  in: Bergan JJ ed, Foam Sclerotherapy – a textbook, Royal Society of Medicine Press Ltd, London, 2008.
• Meissner MH, Eklof B, Smith PC, Dalsing MC, DePalma RG, Gloviczki P, Moneta G, Neglén P, O’ Donnell T, Partsch H, Raju S. Secondary chronic venous disorders.  J Vasc Surg. 2007;46  Suppl S:68S-83S.
• Coleridge Smith P. Inappropriate leukocyte activation in venous disease. In Ed. Bergan JJ, The Vein Book. Academic Press, USA. 2006. pp 57-66.
• Bergan JJ, Schmid-Schonbein GW, Coleridge Smith PD, Nicolaides AN, Boisseau MR, Eklof B.  Chronic venous disease. N Engl J Med. 2006 ;355:488-98.
• Coleridge  Smith PC.  The causes of skin damage and leg ulceration in chronic venous disease. Int J Low Extrem Wounds. 2006 5:160-8.
• Coleridge Smith P.   Chronic Venous Disease Treated by Ultrasound Guided Foam Sclerotherapy. Eur J Vasc Endovasc Surg. 2006 Jun 15
• Howlader MH, Smith PD.  Correlation of severity of chronic venous disease with capillary morphology assessed by capillary microscopy. J Vasc Surg. 2006;43:563-9.
• Coleridge-Smith P, Labropoulos N, Partsch H, Myers K, Nicolaides A, Cavezzi A. Duplex Ultrasound Investigation of the Veins in Chronic Venous Disease of the Lower Limbs-UIP Consensus Document. Part I. Basic Principles. Eur J Vasc Endovasc Surg. 2005 Oct 13
• Cavezzi A, Labropoulos N, Partsch H, Ricci S, Caggiati A, Myers K, Nicolaides A, Coleridge Smith P. Duplex Ultrasound Investigation of the Veins in Chronic Venous Disease of the Lower Limbs-UIP Consensus Document. Part II. Anatomy. Eur J Vasc Endovasc Surg. 2005 Oct 13
• Coleridge-Smith P, Lok C, Ramelet AA. Venous leg ulcer: a meta-analysis of adjunctive therapy with micronized purified flavonoid fraction. Eur J Vasc Endovasc Surg. 2005; 30:198-208.
• Coleridge Smith P. Saphenous ablation: sclerosant or sclerofoam? Semin Vasc Surg. 2005 Mar;18:19-24.
• Degiorgio-Miller AM, Treharne LJ, McAnulty RJ, Coleridge Smith PD, Laurent GJ, Herrick SE.
• Procollagen type I gene expression and cell proliferation are increased in lipodermatosclerosis. Br J Dermatol. 2005;152: 242-9.
• Howlader MH, Coleridge Smith PD. Relationship of plasma vascular endothelial growth factor to CEAP clinical stage and symptoms in patients with chronic venous disease. Eur J Vasc Endovasc Surg. 2004; 27: 89-93.
• Sayer GL, Coleridge Smith PD. Immunocytochemical characterisation of the inflammatory cell infiltrate of varicose veins. Eur J Vasc Endovasc Surg. 2004; 28: 479-83.
• Eklof B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, Meissner MH, Moneta GL, Myers K, Padberg FT, Perrin M, Ruckley CV, Smith PC, Wakefield TW; American Venous Forum International Ad Hoc Committee for Revision of the CEAP Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004; 40:1248-52.
• Coleridge Smith PD. From skin disorders to venous leg ulcers: pathophysiology and efficacy of Daflon 500 mg in ulcer healing. Angiology. 2003; 54 Suppl 1:S45-50.